NeuroPace to Report Third Quarter 2026 Financial Results on November 12, 2026
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2026 after market close on Thursday, November 12, 2026. The companys management will webcast a...